Xiaobo Du

18PUBLICATIONS
32CO-AUTHORS
Gene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsNew Zealand literature (excl. Māori literature)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 09, 2026
Neoadjuvant Pertuzumab Biosimilar HLX11 Versus Reference Pertuzumab for Early-stage or Locally Advanced Breast Cancer: A phase 3 Equivalence Trial.

|May 19, 2026
A Theranostic Study of 177Lu-Labeled Anti-ADAM9 Antibody for the Treatment of Triple-Negative Breast Cancer.

|Jan 22, 2026
Preclinical Study of CDH3-Targeted 89Zr/177Lu Theranostics in Triple-Negative Breast Cancer.

Mingming Tang, Huayan Zhang, Huan Du

|Oct 21, 2025
Ursodeoxycholic acid for the prevention of severe radiation dermatitis: a single-arm phase I/II trial protocol in patients with breast cancer undergoing postoperative radiotherapy in China.

Xinlan Liu, Binwei Lin, Yixue Wen

|Sep 05, 2025
Pain and Its Treatment Among Outpatients with Malignant Tumors in China.

Peiyang Mao, Xin Tian, Yinxia Zhan

|Aug 27, 2025
Risk prediction models for depression in cancer survivors: A systematic review and meta-analysis.

Haonan Xu, Wenqiang Tang, Yuwen Liang

Pageof 3

Frequent Collaborators

1 joint publications

Yao Liao

1 joint publications

Peiyang Mao

1 joint publications

Hongfan Yu

1 joint publications

Qiuling Shi